Covid-19 Vaccine and Hashimoto’s Thyroiditis: A Case Report

Walaa MR El-Meidany1*, Mostafa I Waly2, Peter AM Ntenda3

1Nutrition Department, High Institute of Public Health, Alexandria University, Egypt. 2 Food Science and Nutrition Department, CAMS, Sultan Qaboos University, Oman. 3Malaria Alert Center, Kamuzu university of Health sciences, Malawi

*Correspondence Email Address: w.elmaidany@alexu.edu.eg & mamdouh_loly@yahoo.com

ABSTRACT
Global vaccination campaigns are occurring meanwhile in order to prevent coronavirus disease 2019 (Covid-19). Many vaccines were recommended by the world health organization (WHO). Immunization by Sinovac vaccine is considered safe and has been recommended for persons with comorbidities including obesity, cardiovascular disease and respiratory disease that have been identified as increasing the risk of severe COVID-19. Regarding patients with autoimmune diseases, it was recommended for them to take the Sinovac vaccine safely. In this study we are reporting a case with autoimmune thyroiditis known as Hashimoto’s thyroiditis who had certain signs and symptoms after the first dose of this vaccine, those symptoms were severe pain in the chest, breathlessness, dizziness, palpitation, diffuse weakness and fatigue, diffuse rash on both arms with attacks of chest pain that lasted for two weeks. In the light of this case report, it is clear that patients with autoimmune diseases could react differently than other patients with normal functioning immune system, thus reporting those side effects will provide necessary information to be considered when vaccinating them.

Keywords: Autoimmune Thyroiditis, Covid-19, Sinovac, Vaccination

Citation: El-Meidany WMR, Waly MI, Ntenda PAM. Covid-19 Vaccine and Hashimoto’s Thyroiditis: A Case Report. Canadian Journal of Clinical Nutrition. 2022; 10 (1): 24-28.

DOI: https://dx.doi.org/10.14206/canad.j.clin.nutr.2022.01.04

Download